Evidence map›Paper›PMID 12424623›Full record

ArticleGenes and immunity2002

A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production.

G Morahan, C S Boutlis, D Huang, A Pain, J R Saunders, M R Hobbs, D L Granger, J B Weinberg, N Peshu, E D Mwaikambo and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vasospasm in cerebral inflammation.International journal of inflammation · 2014
    Review
  9. Article
  10. The host genetic diversity in malaria infection.Journal of tropical medicine · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

G MorahanThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. morahan@wehi.edu.au
C S Boutlis
D Huang
A Pain
J R Saunders
M R Hobbs
D L Granger
J B Weinberg
N Peshu
E D Mwaikambo
K Marsh
D J Roberts
N M Anstey
Menzies School of Health Research · AUKenya Medical Research Institute · KEScottish National Blood Transfusion Service · GBUniversity of Utah · USWalter and Eliza Hall Institute of Medical Research · AUDuke University · USMuhimbili Orthopaedic Institute · TZ

Funding

NITRIC OXIDE AND SEVERE MALARIAR01AI041764 · NIAID · DUKE UNIVERSITY · PI WEINBERG, JOE BRICE · 1997 to 2012
$6.3M
NIAID NIH HHS R01 AI41764
6 · The paper itself

Abstract

Interleukin-12 (IL-12) is an important regulatory cytokine in infection and immunity. Administration of IL-12 may reduce complications of severe malaria in rodents. Polymorphisms in IL12B, the gene encoding the IL-12 p40 subunit, influence the secretion of IL-12 and susceptibility to Type 1 diabetes. We therefore investigated whether IL12B polymorphisms may affect the outcome of severe malaria. Homozygosity for a polymorphism in the IL12B promoter was associated with increased mortality in Tanzanian children having cerebral malaria but not in Kenyan children with severe malaria. Furthermore, homozygotes for the IL12B promotor polymorphism had decreased production of nitric oxide, which is in part regulated by IL-12 activity. These studies suggest that IL12B polymorphisms, via regulation of IL-12 production, may influence the outcome of malaria infection in at least one African population.

Indexed as

Promoter Regions, GeneticAnimalsHumansInterleukin-12Interleukin-12 Subunit p40KenyaMalaria, CerebralMolecular Sequence DataNitric OxidePlasmodiumPolymorphism, GeneticProtein SubunitsTanzaniaInterleukin-12Interleukin-12 Subunit p40Nitric OxideProtein Subunits

Identifiers

PMID12424623
OpenAlexW2009881886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.